{"document_type": "article", "byline": {"contributor": "", "person": [{"role": "reported", "firstname": "Stephen", "organization": "", "rank": 1, "lastname": "CASTLE"}], "original": "By STEPHEN CASTLE"}, "news_desk": "Foreign", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/12/26/world/17Euromedicine1/17Euromedicine1-thumbWide.jpg", "legacy": {"wide": "images/2016/12/26/world/17Euromedicine1/17Euromedicine1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/12/26/world/17Euromedicine1/17Euromedicine1-articleLarge.jpg", "legacy": {"xlarge": "images/2016/12/26/world/17Euromedicine1/17Euromedicine1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "401"}, "width": 600, "subtype": "xlarge", "height": 401}, {"type": "image", "url": "images/2016/12/26/world/17Euromedicine1/17Euromedicine1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/12/26/world/17Euromedicine1/17Euromedicine1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "E.U. Agency in Limbo as Hidden \u2018Brexit\u2019 Costs Mount", "main": "E.U. Agency in Limbo as Hidden Costs of \u2018Brexit\u2019 Continue to Mount"}, "print_page": "3", "keywords": [{"value": "Great Britain Withdrawal from EU (Brexit)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "European Medicines Agency", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "European Union", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Great Britain", "is_major": "N", "rank": "4", "name": "glocations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5", "name": "subject"}], "snippet": "The likely move of the European Medicines Agency, currently in Britain, has worrying implications for the country\u2019s vibrant biotech and pharmaceuticals sector....", "source": "The New York Times", "lead_paragraph": "The likely move of the European Medicines Agency, currently in Britain, has worrying implications for the country\u2019s vibrant biotech and pharmaceuticals sector.", "word_count": "1062", "pub_date": "2016-12-25T22:51:28+0000", "subsection_name": "Europe", "blog": [], "type_of_material": "News", "section_name": "World", "web_url": "http://www.nytimes.com/2016/12/25/world/europe/eu-medicines-agency-britain-brexit.html", "_id": "58604d7a95d0e03926077c21"}